Darren Sherman - 28 Jan 2026 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Reporting relationship: President and Chief Operating Officer, Director
Issuer ticker: OBIO
Reported as of: 28 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Feb 2026, 16:15:16 UTC
Prior SEC filing: 02 Jan 2026
Next SEC filing: 13 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Andrew Taylor, Attorney-in-Fact

Key filing fact

Darren Sherman filed Form 4 for Orchestra BioMed Holdings, Inc. (OBIO) on 06 Feb 2026.

Key facts

This page summarizes Darren Sherman's Form 4 filing for Orchestra BioMed Holdings, Inc. (OBIO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Feb 2026, 16:15.

Change

Previous filing in this sequence was filed on 02 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001723524 Primary reporting owner

Sherman Darren

Relationship: President and Chief Operating Officer, Director
Address: C/O ORCHESTRA BIOMED HOLDINGS, INC., 150 UNION SQUARE DRIVE, NEW HOPE
Signature: /s/ Andrew Taylor, Attorney-in-Fact
Signature date: 06 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OBIO transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +34,974
Change %
Price: $0.000000
Shares after: 34,974
Date: 28 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 34,974
Exercise price: $2.85
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This date represents the date of vesting of a performance stock option granted on April 23, 2025.

Footnote F2

The stock option vests over a four-year period as follows: 25% on the April 23, 2026 (the "Vesting Commencement Date") with the remaining 75% vesting in equal installments every three months thereafter on the same day of the month as the Vesting Commencement Date over a three-year period, commencing in the third month after the Vesting Commencement Date.

SEC remarks

President and Chief Operating Officer